Medical specialists from France tagged as investigators in clinical trials studying Diffuse Intrinsic Pontine Glioma

Total 32 results

Anne Isabelle BERTOZZI SALAMON, MD
Seen in:
- Toulouse, Hôpital des Enfants
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Anne Pagnier, MD
Seen in:
- Grenoble, CHU Grenoble Alpes
- Grenoble, CHU Grenoble Alpes - Hôpital Couple-Enfant
- Grenoble, Grenoble CHU
- Isère, La Tronche, CHU GRENOBLE - Hôpital Couple-Enfant
Trials:
- NCT05476939 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT02265770 (Principal Investigator)
Conditions:
Bérangère NARCISO-RAHARIMANANA, MD
Seen in:
- Tours, CHRU Tours - Hopital Bretonneau
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Camille KHANFAR, MD
Seen in:
- Amiens, CHU Amiens Picardie
- Amiens, CHU d'Amiens-Picardie Site Sud
- Amiens, Hopital Nord Chu Amiens
Trials:
- NCT05476939 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions:
Céline ICHER de BOUYN, MD
Seen in:
- Bordeaux, CHU de Bordeaux - Groupe hospitalier Pellegrin - Hôpital des enfants
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Charlotte BRONNIMANN, MD
Seen in:
- Bordeaux, CHU
- Bordeaux, CHU de Bordeaux - Groupe hospitalier Saint André - Hôpital Saint André
Trials:
- NCT05476939 (Principal Investigator)
- NCT03212742 (Principal Investigator)
Conditions:
Chloé PUISEUX, MD
Seen in:
- Rennes, CHU Rennes - Hôpital sud
- Rennes, CHU de Rennes
- Rennes, Rennes CHU
Trials:
- NCT05476939 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions:
Christophe Piguet, MD
Seen in:
- Limoges, CHU Limoges
- Limoges, Hôpital de la mère et de l'enfant
Trials:
- NCT05476939 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions:
Claire BERGER, MD
Seen in:
- Saint-Étienne, CHU de Saint-Etienne - Hôpital Nord
- Saint-Étienne, Hopital Nord
Trials:
- NCT05476939 (Principal Investigator)
- NCT05192980 (Principal Investigator)
Conditions:
Claire Briandet, MD
Seen in:
- Côte d'Or, Dijon, CHU Dijon - Hôpital des Enfants
- Dijon, CHU Bocage
- Dijon, CHU Francois Mitterrand
- Dijon, DIJON CHU Hopital François Mitterand
- Dijon, DIJON Hôpital d'enfants
- Strasbourg, Service de Pédiatrie 3
Trials:
- NCT05476939 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT02870907 (Principal Investigator)
- NCT03690570 (Principal Investigator)
Conditions:
Elodie VAULEON, MD
Seen in:
- Rennes, Centre Eugene Marquis
Trials:
- NCT05476939 (Principal Investigator)
- NCT03212742 (Principal Investigator)
Conditions:
Emilie De Carli, MD
Seen in:
- Angers, CHU d'Angers
- Angers, CHU d'Angers - Bâtiment Robert Debré
- Maine-et-Loire, Angers, Chu Angers
Trials:
- NCT05476939 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT02265770 (Principal Investigator)
Conditions:
Franck BOURDEAUT, MD
Seen in:
- Paris, Institut Curie
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Frédéric MILLOT, MD, PhD
Seen in:
- Poitiers, CHU Poitiers
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Gilles Palenzuela, MD
Seen in:
- Herault, Montpellier, CHRU MONTPELLIER - Hôpital Arnaud de Villeneuve
- Montpellier, Hôpital Arnaud de Villeneuve
Trials:
- NCT05476939 (Principal Investigator)
- NCT02265770 (Principal Investigator)
Conditions:
Gwénaëlle DUHIL DE BENAZE, MD
Seen in:
- Nice, CHU Nice - Hôpital de l'Archet 2
- Nice, CHU de Nice - Hôpital L'Archet 2
- Nice, NICE CHU Hopital Archet 2
Trials:
- NCT05476939 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT02265770 (Principal Investigator)
Conditions:
Jacques GRILL, MD, PhD
Seen in:
- Val De Marne, Villejuif, Gustave Roussy
Trials:
- NCT05476939 (Principal Investigator)
- NCT02233049 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Liana CARAUSU, MD
Seen in:
- Brest, CHRU Brest
- Brest, CHRU de Brest - Hôpital Morvan
- Brest, Chu de Brest Morvan
Trials:
- NCT05476939 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT05192980 (Principal Investigator)
Conditions:
Luc TAILLANDIER, MD, PhD
Seen in:
- Nancy, CHRU Nancy - Hôpital central
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Marianna DEPARIS, MD
Seen in:
- Caen, CHU caen
- Caen, CHU de Caen - Hopital Cote de Nacre
Trials:
- NCT05476939 (Principal Investigator)
- NCT05180825 (Principal Investigator)
Conditions:
Marion GILLIBERT-YVERT, MD
Seen in:
- Tours, CHRU Tours - Hôpital Clocheville
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Mehdi Touat, MD
Seen in:
- Paris, Hopital Piti-Salpetriere
- Paris, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix
Trials:
- NCT05476939 (Principal Investigator)
- NCT03970447 (Principal Investigator)
Conditions:
Natacha ENTZ-WERLE, MD, PhD
Seen in:
- Strasbourg, Hopital de Hautepierre
- Strasbourg, Service Pédiatrie Onco-hématologie - Pédiatrie III - CHU de Strasbourg - France
- Strasbourg, Service Pédiatrie Onco-hématologie - Pédiatrie III - Hôpitaux Universitaires de Strasbourg
- Strasbourg, Service d'onco-hématologie pédiatrique - CHU de Strasbourg - France
- Strasbourg, Service de Pédiatrie 3
Trials:
- NCT05476939 (Principal Investigator)
- NCT05617131 (Principal Investigator)
- NCT05107843 (Principal Investigator)
- NCT03690570 (Principal Investigator)
- NCT06171971 (Principal Investigator)
Conditions:
Nicolas André, MD, PhD
Seen in:
- Bouches-du-Rhône, Marseille, AP-HM - Hôpital d'Enfants de La Timone
- Marseille, Hopital de La Timone
Trials:
- NCT05476939 (Principal Investigator)
- NCT02265770 (Principal Investigator)
Conditions:
Pascal Chastagner, MD
Seen in:
- Meurthe-et-Moselle, Vandoeuvre-les-Nancy, CHU NANCY - Brabois Hôpital d'Enfants
- Nancy, CHRU Nancy Brabois - Hôpital d'Enfants
Trials:
- NCT05476939 (Principal Investigator)
- NCT02265770 (Principal Investigator)
Conditions:
Pascale SCHNEIDER, MD, PhD
Seen in:
- Rouen, CHU Rouen Normandie - Hôpital Charles-Nicolle
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Paule AUGEREAU, MD
Seen in:
- Angers, ICO Paul Papin
- Angers, Institut de Cancérologie de l'Ouest
- Angers, Institut de Cancérologie de l'Ouest (ICO) - Site Paul Papin
Trials:
- NCT05476939 (Principal Investigator)
- NCT02653105 (Principal Investigator)
- NCT05201547 (Principal Investigator)
Conditions:
Pierre LEBLOND, MD, PhD
Seen in:
- Lyon, Centre LEON BERARD
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Sandra RAIMBAULT, MD
Seen in:
- Lille, Centre OSCAR LAMBRET
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant
Stefania CUZZUBBO, MD
Seen in:
- Paris, Hôpital Saint louis
Trials:
- NCT05476939 (Principal Investigator)
Conditions:
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant

Clinical Trials on Diffuse Intrinsic Pontine Glioma

National Cancer Institute (NCI)

Recruiting

Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

Recurrent Malignant Glioma | Recurrent Medulloblastoma | Refractory Malignant Glioma | Refractory Medulloblastoma | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Refractory Diffuse Intrinsic Pontine...

United States, Canada
Sidney Kimmel Comprehensive Cancer Center at Johns...
Solving Kids' Cancer

Completed

Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).

Diffuse Intrinsic Pontine Glioma (DIPG)

United States
University of California, San Francisco
Translational Genomics Research Institute

Completed

Molecular Profiling for Individualized Treatment Plan for DIPG

Diffuse Intrinsic Pontine Glioma (DIPG)

United States
University of California, San Francisco
National Institute of Neurological Disorders and Stroke (NINDS); The Chad-Tough... and other collaborators

Recruiting

Combination Therapy for the Treatment of Diffuse Midline Gliomas

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Diffuse Midline Glioma, H3 K27M-Mutant | Recurrent WHO Grade III Glioma | WHO Grade III Glioma

United States, Israel, Australia, Netherlands, Switzerland, New Zealand
University of Florida
Accelerate Brain Cancer Cure; Lyla Nsouli Foundation

Active, not recruiting

Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (BRAVO)

Brain Stem Glioma | Diffuse Intrinsic Pontine Glioma (DIPG)

United States
Burzynski Research Institute

Suspended

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

Diffuse, Intrinsic Pontine Glioma

United States
Shenzhen Geno-Immune Medical Institute
Shenzhen Children's Hospital; Shenzhen Hospital of Southern Medical University

Unknown

Immune Modulatory DC Vaccine Against Brain Tumor

Diffuse Intrinsic Pontine Glioma or Glioblastoma

China
Hadassah Medical Organization

Completed

Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children

Pediatric Malignant Brain Tumor -Diffuse Intrinsic Pontine Glioma

Israel
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Malignant Glioma | Recurrent Childhood Ependymoma | Recurrent Medulloblastoma | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Atypical Teratoid/Rhabdoid Tumor | Refractory Diffuse Intrinsic Pontine Glioma | CNS Embryonal Tumor, Not Otherwise Specified

United States
Cheng-Chia (Fred) Wu
Focused Ultrasound Foundation

Active, not recruiting

Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG)

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Diffuse Pontine and Thalamic Gliomas

United States

Medical specialists from France tagged as investigators in clinical trials studying Diffuse Intrinsic Pontine Glioma

Clinical Trials on Diffuse Intrinsic Pontine Glioma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations